OxFORD Asset Management LLP lessened its position in Analogic Co. (NASDAQ:ALOG) by 4.0% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 32,287 shares of the medical research company’s stock after selling 1,350 shares during the period. OxFORD Asset Management LLP owned approximately 0.26% of Analogic worth $2,710,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in ALOG. Vanguard Group Inc. boosted its holdings in shares of Analogic by 3.1% in the second quarter. Vanguard Group Inc. now owns 1,147,408 shares of the medical research company’s stock worth $83,359,000 after buying an additional 34,765 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Analogic by 4.1% during the third quarter. Dimensional Fund Advisors LP now owns 947,627 shares of the medical research company’s stock worth $79,364,000 after purchasing an additional 37,066 shares during the period. Wells Fargo & Company MN boosted its holdings in shares of Analogic by 1.8% during the second quarter. Wells Fargo & Company MN now owns 785,205 shares of the medical research company’s stock worth $57,045,000 after purchasing an additional 14,180 shares during the period. Northern Trust Corp boosted its holdings in shares of Analogic by 53.5% during the second quarter. Northern Trust Corp now owns 372,687 shares of the medical research company’s stock worth $27,075,000 after purchasing an additional 129,855 shares during the period. Finally, Ameriprise Financial Inc. raised its position in Analogic by 10.6% during the third quarter. Ameriprise Financial Inc. now owns 354,655 shares of the medical research company’s stock valued at $29,703,000 after acquiring an additional 34,021 shares in the last quarter. 97.68% of the stock is currently owned by institutional investors and hedge funds.
Analogic Co. (NASDAQ ALOG) traded up $0.50 during trading on Tuesday, hitting $84.25. The company had a trading volume of 75,194 shares, compared to its average volume of 64,800. The company has a market capitalization of $1,070.00, a PE ratio of -14.75, a price-to-earnings-growth ratio of 4.18 and a beta of 0.86. Analogic Co. has a fifty-two week low of $66.00 and a fifty-two week high of $89.50.
Analogic (NASDAQ:ALOG) last announced its quarterly earnings data on Wednesday, December 6th. The medical research company reported $0.75 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.43 by $0.32. The firm had revenue of $106.90 million during the quarter, compared to analysts’ expectations of $100.55 million. Analogic had a positive return on equity of 5.09% and a negative net margin of 15.06%. The company’s quarterly revenue was down 11.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.43 EPS. analysts forecast that Analogic Co. will post 2.86 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 29th. Investors of record on Friday, December 15th were given a $0.10 dividend. The ex-dividend date was Thursday, December 14th. This represents a $0.40 annualized dividend and a dividend yield of 0.47%. Analogic’s dividend payout ratio is presently -7.01%.
A number of equities analysts have recently commented on the stock. Zacks Investment Research raised shares of Analogic from a “hold” rating to a “buy” rating and set a $93.00 price target on the stock in a research report on Tuesday, October 10th. Jefferies Group reaffirmed a “hold” rating and set a $80.00 target price on shares of Analogic in a research report on Friday, December 8th. Finally, BidaskClub lowered shares of Analogic from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $88.33.
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.